B
Biosis Healing
Regenerative medical materials for surgical tissue repair
About Biosis Healing
Founded in 2012 by Dr. Zhao Bo, a surgeon, Beijing Biosis Healing Biological Technology Co., Ltd. develops and manufactures biomaterials and medical devices for tissue repair and regeneration. Dr. Zhao's clinical background provided insight into the need for advanced surgical solutions, leading him to establish the company to localize and innovate Small Intestinal Submucosa (SIS) biomaterial technology, which was previously monopolized by foreign markets.
The company's core business revolves around its proprietary non-crosslinked extracellular matrix (ECM) derived from SIS. This biomaterial acts as a natural scaffold that allows a patient's own cells to migrate, integrate, and regenerate damaged tissue, eventually remodeling into healthy, functional tissue without leaving permanent foreign material. This technology is applied across a wide range of products for various surgical fields, including general surgery, neurosurgery, dental surgery, bariatric surgery, and wound management. Key products include hernia repair grafts, dural repair patches, dental membranes, and staple line reinforcements. In addition to its regenerative materials, Biosis Healing also produces a line of minimally invasive surgical instruments, such as disposable staplers and trocars, which have received CE and FDA approvals.
Biosis Healing's business model focuses on research and development, manufacturing, and global distribution of its medical devices. The company serves hospitals and clinics, providing surgeons with tools for procedures like hernia repair, sleeve gastrectomy, and various soft tissue repairs. Having received national recognition as a high-tech enterprise in China and funding for its R&D, the company holds numerous national and international patents for its core technologies in the US, UK, and Germany. Its products are sold in over 30 countries.
Source: Dealroom company dataNews
Open roles
Biosis Healing in the Daxing District ecosystem
The Biosis Healing office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- DCDingxin Capital
Proxima Ventures
Med-Fine Capital
Series B and later1 investor entered at this stage
- QCQS Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biosis Healing on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biosis Healing on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.